A23L33/105

COMPOSITION CONTAINING CANNABINOIDS

Self-emulsifying compositions are disclosed that form stable monodispersions in aqueous solutions containing relatively high concentrations of cannabinoids. They can be easily diluted in aqueous solutions. This makes them suitable for the production of water-based oral products, in particular pharmaceutical compositions, medical devices or food products.

COMPOSITION CONTAINING CANNABINOIDS

Self-emulsifying compositions are disclosed that form stable monodispersions in aqueous solutions containing relatively high concentrations of cannabinoids. They can be easily diluted in aqueous solutions. This makes them suitable for the production of water-based oral products, in particular pharmaceutical compositions, medical devices or food products.

Flavored Compositions and Related Methods
20230014339 · 2023-01-19 ·

Flavored compositions and methods of production and use. A flavored composition may be produced by extracting a psychoactive portion from a first Cannabis tissue to produce an extracted tissue and combining the extracted tissue with a flavor composition, according to a first ratio, to produce a flavored extracted tissue. A second Cannabis tissue may be processed to produce a processed tissue, and the flavored extracted tissue may be combined with the processed tissue according to a second ratio to produce the flavored composition. The flavored composition may contain a defined amount of a psychoactive compound.

Flavored Compositions and Related Methods
20230014339 · 2023-01-19 ·

Flavored compositions and methods of production and use. A flavored composition may be produced by extracting a psychoactive portion from a first Cannabis tissue to produce an extracted tissue and combining the extracted tissue with a flavor composition, according to a first ratio, to produce a flavored extracted tissue. A second Cannabis tissue may be processed to produce a processed tissue, and the flavored extracted tissue may be combined with the processed tissue according to a second ratio to produce the flavored composition. The flavored composition may contain a defined amount of a psychoactive compound.

Savoury concentrate

The invention provides a savoury concentrate comprising: a) at least 30 wt. %, by weight of the concentrate, of an oil phase comprising liquid oil; b) 3-30 wt. %, by weight of the concentrate, of edible salt selected from sodium chloride, potassium chloride and combinations thereof; c) 1-50 wt. %, by weight of the concentrate, of savoury taste giving ingredients selected from glutamate, 5′-ribonucleotides, sucrose, glucose, fructose, lactic acid, citric acid and combinations thereof; d) up to 10 wt. %, by weight of the concentrate, of water; and e) particulate anhydrous non-defibrillated cell wall material from plant tissue selected from parenchymal plant tissue, stem tissue of monocotyledon plants and combinations thereof, said particulate anhydrous non-defibrillated cell wall material having a particle size of between 25 μm and 500 μm;
wherein the particulate anhydrous non-defibrillated cell wall material is dispersed in the oil phase in a concentration of 0.05 to 15 wt. %, by weight of the liquid oil. The particulate anhydrous non-defibrillated cell wall material from parenchymal pant tissue and/or stem tissue of monocotyledon plants is capable of forming an oil-retaining matrix within the liquid oil and thereby minimize oil exudation.

Savoury concentrate

The invention provides a savoury concentrate comprising: a) at least 30 wt. %, by weight of the concentrate, of an oil phase comprising liquid oil; b) 3-30 wt. %, by weight of the concentrate, of edible salt selected from sodium chloride, potassium chloride and combinations thereof; c) 1-50 wt. %, by weight of the concentrate, of savoury taste giving ingredients selected from glutamate, 5′-ribonucleotides, sucrose, glucose, fructose, lactic acid, citric acid and combinations thereof; d) up to 10 wt. %, by weight of the concentrate, of water; and e) particulate anhydrous non-defibrillated cell wall material from plant tissue selected from parenchymal plant tissue, stem tissue of monocotyledon plants and combinations thereof, said particulate anhydrous non-defibrillated cell wall material having a particle size of between 25 μm and 500 μm;
wherein the particulate anhydrous non-defibrillated cell wall material is dispersed in the oil phase in a concentration of 0.05 to 15 wt. %, by weight of the liquid oil. The particulate anhydrous non-defibrillated cell wall material from parenchymal pant tissue and/or stem tissue of monocotyledon plants is capable of forming an oil-retaining matrix within the liquid oil and thereby minimize oil exudation.

METHOD FOR PRODUCING A PURIFIED CANNABACEAE BIOMASS EXTRACT

The present disclosure relates to a method for producing a purified cannabaceae biomass extract, wherein a crude alcoholic cannabaceae biomass extract comprising at least two cannabinoid compounds in an alcoholic solvent is circulating through a powdered layer of activated carbon and the purified cannabaceae biomass extract is recovered with a ratio of cannabinoid compounds in the purified cannabaceae biomass extract is higher than the ratio of the cannabinoid compounds in the crude alcoholic cannabaceae biomass extract.

HEMP SPROUT PRODUCTS AND METHODS FOR PRODUCING SAME
20230218693 · 2023-07-13 ·

The present invention relates to hemp products, such as sprouted hemp seed products, and methods for producing the same. The methods preserve the nutritional values of hemp seeds prior to processing.

HEMP SPROUT PRODUCTS AND METHODS FOR PRODUCING SAME
20230218693 · 2023-07-13 ·

The present invention relates to hemp products, such as sprouted hemp seed products, and methods for producing the same. The methods preserve the nutritional values of hemp seeds prior to processing.

PHARMACEUTICAL COMPOSITION CONTAINING SAURURUS CHINENSIS FRACTION, AND PREPARATION METHOD THEREOF
20230218701 · 2023-07-13 ·

The present disclosure relates to a pharmaceutical composition for preventing, treating or ameliorating inflammatory bowel disease, containing, as an active ingredient, a specific solvent fraction obtained from Saururus chinensis; and a preparation method therefor.